Evidence map›Paper›PMID 27564129›Full record

ArticleCell cycle (Georgetown, Tex.)2016

TBP loading by AF4 through SL1 is the major rate-limiting step in MLL fusion-dependent transcription.

Hiroshi Okuda, Satoshi Takahashi, Akifumi Takaori-Kondo, Akihiko Yokoyama

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Molecular processes involved in B cell acute lymphoblastic leukaemia.Cellular and molecular life sciences : CMLS · 2018
    Review
  12. Review
  13. Bio-protocol · 2017
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hiroshi Okudaa Laboratory for Malignancy Control Research , Kyoto University Graduate School of Medicine , Kyoto , Japan.
Satoshi Takahashib Department of Hematology and Oncology , Graduate School of Medicine , Kyoto , Japan.
Akifumi Takaori-Kondob Department of Hematology and Oncology , Graduate School of Medicine , Kyoto , Japan.
Akihiko Yokoyamaa Laboratory for Malignancy Control Research , Kyoto University Graduate School of Medicine , Kyoto , Japan.
Kyoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gene rearrangement of the mixed lineage leukemia (MLL) gene causes leukemia by inducing the constitutive expression of a gene subset normally expressed only in the immature haematopoietic progenitor cells. MLL gene rearrangements often generate fusion products of MLL and a component of the AF4 family/ENL family/P-TEFb (AEP) complex. MLL-AEP fusion proteins have the potential of constitutively recruiting the P-TEFb elongation complex. Thus, it is hypothesized that relieving the promoter proximal pausing of RNA polymerase II is the rate-limiting step of MLL fusion-dependent transcription. AEP also has the potential to recruit the mediator complex via MED26. We recently showed that AEP activates transcription initiation by facilitating TBP loading to the TATA element through the SL1 complex. In the present study, we show that the key activity responsible for the oncogenic property of MLL-AEP fusion proteins is the TBP loading activity, and not the mediator recruitment or transcriptional elongation activities. Thus, we propose that TBP loading by AF4 through SL1 is the major rate-limiting step in MLL fusion-dependent transcription.

Indexed as

Transcription, GeneticAmino Acid MotifsAmino Acid SequenceAnimalsCell Transformation, NeoplasticConserved SequenceDNA-Binding ProteinsMice, Inbred C57BLModels, BiologicalMyeloid CellsMyeloid-Lymphoid Leukemia ProteinOncogene Proteins, FusionProtein DomainsTATA-Box Binding ProteinTranscriptional ActivationDNA-Binding ProteinsMyeloid-Lymphoid Leukemia ProteinOncogene Proteins, FusionTATA-Box Binding ProteinAF4leukemiamediatorMLLSL1TBPtranscription

Identifiers

PMID27564129
PMCPMC5053588
OpenAlexW2510230188

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.